Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, ...

due to the soaring demand for these weight loss drugs, it’s now a mainstream phenomenon. Semaglutide has been on the market for 20 years, but it was approved by the FDA in 2021 for chronic ...

contains the same active ingredient as the brand-name medications (but it hasn’t been approved by the FDA). As a weight loss drug, semaglutide is intended to be used along with lifestyle changes ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ... While Zepbound is FDA-approved for weight loss, Mounjaro is approved for managing type 2 diabetes. Adults without diabetes ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected ... reward,'' Hendershot noted. However, no FDA-approved medications currently exist to treat ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that was originally approved by the ... irrespective of starting weight and amount of weight loss. 8 Based on the SELECT trial ...